Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 1,681–1,688 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Erytech Pharma S.A. GRASPA (Eryaspase) Acute lymphoblastic leukemia (ALL) BLA Filing Intravenous Oncology
Esperion Therapeutics Inc. Bempedoic acid - (Japan trial) Hypercholesterolemia Phase 3 Data Released Oral Cardiology
Esperion Therapeutics Inc. NEXLETOL (bempedoic acid) / Ezetimibe (1002-058) LDL-C and type 2 diabetes Phase 2 Trial Completed Oral Endocrinology
Esperion Therapeutics Inc. Bempedoic Acid Pediatric Heterozygous and Homozygous Familial Hypercholesterolemia Phase 3 Trial Planned Oral Cardiology
Esperion Therapeutics Inc. Bempedoic acid - (Japan trial) Hypercholesterolemia Phase 3 Data Released Oral Cardiology
ESSA Pharma Inc. EPI-7386 in Combination with Enzalutamide Metastatic castration-resistant prostate cancer (mCRPC) Phase 2 Ongoing oral Oncology
ETHZilla Corp Com Par $0.0001 Anti-TNF program Dupuytren’s disease (DD) Phase 2/3 Subcutaneous or intravenous Orthopedic
ETHZilla Corp Com Par $0.0001 Fibrosis & Anti-TNF Post Operative Delirium/Cognitive Deficit (POCD) Phase 2 Subcutaneous Neurology
1…209210211212213…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.